Artigos (87)

¹ Publicaciones consideradas como producción de la unidad.

Ver datos de investigación referenciados.

no ano 2017 Eliminar o filtro
filter_list Tipo (agr.) Artigos Desde o ano 2017 Ata o ano 2017

2017

  1. 3-Oxopyridazin-5-yl-Chalcone Hybrids: Potent Antiplatelet Agents That Prevent Glycoprotein IIb/IIIa Activation

    ChemistrySelect, Vol. 2, Núm. 17, pp. 4920-4933

  2. A Positive Allosteric Modulator of the Serotonin 5-HT2C Receptor for Obesity

    Journal of Medicinal Chemistry, Vol. 60, Núm. 23, pp. 9575-9584

  3. Achieving antimicrobial activity through poly(N-methylvinylimidazolium) iodide brushes on binary-grafted polypropylene suture threads

    MRS Communications, Vol. 7, Núm. 4, pp. 938-946

  4. Adherence and safety study in patients on treatment with capecitabine

    Farmacia Hospitalaria, Vol. 41, Núm. 2, pp. 204-221

  5. Advances on the formulation of proteins using nanotechnologies

    Journal of Drug Delivery Science and Technology, Vol. 42, pp. 155-180

  6. Assessment of the permeability and toxicity of polymeric nanocapsules using the zebrafish model

    Nanomedicine, Vol. 12, Núm. 17, pp. 2069-2082

  7. Biodegradable PCL/fibroin/hydroxyapatite porous scaffolds prepared by supercritical foaming for bone regeneration

    International Journal of Pharmaceutics, Vol. 527, Núm. 1-2, pp. 115-125

  8. Biodistribution of radiolabeled polyglutamic acid and PEG-polyglutamic acid nanocapsules

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 112, pp. 155-163

  9. Biomaterials to suppress cancer stem cells and disrupt their tumoral niche

    International Journal of Pharmaceutics, Vol. 523, Núm. 2, pp. 490-505

  10. Burden assessment in caregivers of patients with home artificial nutrition: A need and a challenge

    European Journal of Clinical Nutrition, Vol. 71, Núm. 2, pp. 192-197

  11. Chitosan-coated mesoporous MIL-100(Fe) nanoparticles as improved bio-compatible oral nanocarriers

    Scientific Reports, Vol. 7

  12. Cis-Platinum Complex Encapsulated in Self-Assembling Cyclic Peptide Dimers

    Organic Letters, Vol. 19, Núm. 10, pp. 2560-2563

  13. Clinical Experience with the Integrase Inhibitors Dolutegravir and Elvitegravir in HIV-infected Patients: Efficacy, Safety and Tolerance

    Basic and Clinical Pharmacology and Toxicology, Vol. 121, Núm. 5, pp. 442-446

  14. Clinical profile and outcomes in octogenarians with atrial fibrillation: A community-based study in a specific European health care area

    International Journal of Cardiology, Vol. 243, pp. 211-215

  15. Computer-aided design of multi-target ligands at A1R, A2AR and PDE10A, key proteins in neurodegenerative diseases

    Journal of Cheminformatics, Vol. 9, Núm. 1

  16. Contralateral choroiditis secondary to combination therapy with simeprevir, sofosbuvir and ribavirin

    European Journal of Clinical Pharmacy, Vol. 19, Núm. 4, pp. 291-293

  17. Cyclodextrins as versatile building blocks for regenerative medicine

    Journal of Controlled Release, Vol. 268, pp. 269-281

  18. Cysteamine ophthalmic hydrogel for the treatment of ocular cystinosis

    Farmacia Hospitalaria, Vol. 41, Núm. 6, pp. 678-687

  19. Cysteamine polysaccharide hydrogels: Study of extended ocular delivery and biopermanence time by PET imaging

    International Journal of Pharmaceutics, Vol. 528, Núm. 1-2, pp. 714-722

  20. Development of Fluorescent Probes that Target Serotonin 5-HT2B Receptors

    Scientific Reports, Vol. 7, Núm. 1